Table 2 The 3-year local control, disease-free survival, metastasis-free survivaland overall survival rates of cisplatin versus carboplatin
Parameters | Cisplatin (N = 137) | Carboplatin (N = 76) | p-value |
|---|---|---|---|
Local control | 94.9 % | 89.5 % | 0.13 |
Disease-free survival | 81.8 % | 78.9 % | 0.62 |
Metastasis-free survival | 83.9 % | 86.8 % | 0.56 |
Overall survival | 86.1 % | 89.5 % | 0.48 |